The challenges of hepatitis C management in Iran: A qualitative study with patients.

Autor: Behzadifar M; Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran., Azari S; Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran., Gorji HA; Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran., Rezapour A; Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran., Bragazzi NL; Postgraduate School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.; Laboratory for Industrial and Applied Mathematics (LIAM), Department of Mathematics and Statistics, York University, Toronto, ON, Canada.
Jazyk: angličtina
Zdroj: The International journal of health planning and management [Int J Health Plann Manage] 2020 Jan; Vol. 35 (1), pp. e56-e65. Date of Electronic Publication: 2019 Nov 03.
DOI: 10.1002/hpm.2927
Abstrakt: Background: The patient's perspective concerning the treatment process and the knowledge of the challenges and problems that they encounter can help to improve their treatment conditions.
Aim: The present study aimed at analyzing the experiences of hepatitis C virus (HCV) patients in Iran and the challenges encountered during the management and treatment process.
Methods: Semi-structured in-depth and face-to-face interviews were conducted. The criteria for selecting patients were as follows: HCV-positive subjects, with confirmed diagnosis of HCV, and under treatment. Content analysis was used to analyze the data. MAXQDA Ver11 software was used to better manage data. This study is based on the "Consolidated Criteria for Reporting Qualitative Research" (COREQ) checklist.
Results: Twenty-one HCV patients were interviewed. The mean age of participants was 36.14 ± 11.29 years. Seven themes with 20 subthemes emerged from the content analysis of the interviews, namely, (a) disease-related stigma, (b) lack of knowledge, (c) psychological problems, (d) financial problems, (e) complications of treatment, (f) lack of family and community support, and (g) health-care system.
Conclusion: The findings of this study showed that a range of economic, social, and cultural problems could affect the treatment of HCV patients. Health policy and decision makers should try to provide them with a better management.
(© 2019 John Wiley & Sons, Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje